Glucose-lowering effects of sulfasalazine in type 2 diabetes.
Haas
Romana M
RM
Stanford University School of Medicine, Division of Endocrinology, California, USA.
Li
Phoebe
P
Chu
James W
JW
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D012460:Sulfasalazine
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D012460:Sulfasalazine